The association between fatalistic beliefs and late stage at diagnosis of lung and colorectal cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 4, 2015, Pages 720-726

  Lyratzopoulos, Georgios ^a,c   Liu, Michael Pang Hsiang ^b   Abel, Gary A ^a   Wardle, Jane ^c   Keating, Nancy L ^b,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; COLORECTAL CANCER; COMORBIDITY; EDUCATION; ETHNIC OR RACIAL ASPECTS; FATALISTIC BELIEF; FEMALE; HEALTH BEHAVIOR; HEALTH BELIEF; HEALTH STATUS; HELP SEEKING BEHAVIOR; HUMAN; INCOME; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PUBLIC HEALTH; SMOKING; UNITED STATES; VERY ELDERLY; ATTITUDE TO HEALTH; CATASTROPHIZING; COLORECTAL TUMOR; LUNG TUMOR; PATHOLOGY; PSYCHOLOGY; RISK; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CATASTROPHIZATION; COLORECTAL NEOPLASMS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RISK; YOUNG ADULT;

EID: 84927932891     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0969     Document Type: Article

References (31)

1. Elliss-Brookes L, McPhail S, Ives A, Greenslade M, Shelton J, Hiom S, et al. Routes to diagnosis for cancer-determining the patient journey using multiple routine data sets. Br J Cancer 2012;107:1220-6.
2. Lyratzopoulos G. Measures and markers of timeliness of diagnosis in symptomatic patients. A conceptual framework and its implications. Cancer Epidemiol 2014;38:211-3.
3. Weller D, Vedsted P, Rubin G,Walter FM, Emery J, Scott S, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer 2012;106:1262-7.
4. Simon AE, Forbes LJ, Boniface D, Warburton F, Brain KE, Dessaix A, et al. An internationalmeasure of awareness and beliefs about cancer: development and testing of the ABC. BMJ Open 2012;2 pii: e001758.
5. Powe BD, Finnie R. Cancer fatalism: the state of the science. Cancer Nurs 2003;26:454-65.
6. Facione NC, Miaskowski C, Dodd MJ, Paul SM. The self-reported likelihood of patient delay in breast cancer: new thoughts for early detection. Prev Med 2002;34:397-407.
7. Beeken RJ, Simon AE, von Wagner C, Whitaker KL, Wardle J. Cancer fatalism: deterring early presentation and increasing social inequalities? Cancer Epidemiol Biomarkers Prev 2011;20:2127-31.
8. Powe BD. Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs 1995;18:385-92.
9. Lostao L, Joiner TE, Pettit JW, Chorot P, Sandín B. Health beliefs and illness attitudes as predictors of breast cancer screening attendance. Eur J Public Health 2001;11:274-9.
10. Peek ME, Sayad JV,Markwardt R. Fear, fatalismand breast cancer screening in low-income African-American women: the role of clinicians and the health care system. J Gen Intern Med 2008;23:1847-53.
11. Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 1998;279:1801-7.
12. Bergamo C, Lin JJ, Smith C, Lurslurchachai L, Halm EA, Powell CA, et al. Evaluating beliefs associated with late-stage lung cancer presentation in minorities. J Thorac Oncol 2013;8:12-8.
13. Malin JL, Ko C, Ayanian JZ, Harrington D, Nerenz DR, Kahn KL, et al. Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer 2006;14:837-48.
14. Ayanian JZ, Chrischilles EA, Fletcher RH, Fouad MN, Harrington DP, Kahn KL, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 2004;22: 2992-6.
15. Catalano PJ, Ayanian JZ,Weeks JC, Kahn KL, Landrum MB, Zaslavsky AM, et al. Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care 2013;51:e9-15.
16. Jacobson CK. Denominational and racial and ethnic differences in fatalism. Rev Relig Res 1999;41:9-20.
17. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996;34:73-84.
18. Little RJ. Direct standardization: a tool for teaching linear models for unbalanced data. Am Stat 1982;36:38-43.
19. He Y, Zaslavsky AM, Landrum MB, Harrington DP, Catalano P. Multiple imputation in a large-scale complex survey: a practical guide. StatMethods Med Res 2010;19:653-70.
20. Mohamed IE, Skeel Williams K, Tamburrino M, Wryobeck J, Carter S. Understanding locally advanced breast cancer: what influences a woman's decision to delay treatment? Prev Med 2005;41:399-405.
21. Cohen M. Cancer fatalism. Attitudes toward screening and care. 1st ed. Carr BI, Steel J, editors. Springer US: Psychological Aspects of Cancer; 2013.
22. Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, Fan L, Li J, Chavarri-Guerra Y, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 2014;15:489-538.
23. Keeley B, Wright L, Condit CM. Functions of health fatalism: fatalistic talk as face saving, uncertainty management, stress relief and sense making. Sociol Health Illn 2009;31:734-47.
24. Quaife SL, Forbes LJ, Ramirez AJ, Brain KE, Donnelly C, Simon AE, et al. Recognition of cancer warning signs and anticipated delay in helpseeking in a population sample of adults in the UK. Br J Cancer 2014; 110:12-8.
25. Shen L, Condit CM, Wright L. The psychometric property and validation of a fatalism scale. Psychol Health 2009;24:597-613.
26. Groves R. Nonresponse rates and nonresponse bias in household surveys. Public Opin Q 2006;70:646-75.
27. Groves R, Peytcheva E. The impact of nonresponse rates on nonresponse bias: a meta-analysis. Public Opin Q 2008;72:167-89.
28. Powe BD. Do recently diagnosed black breast cancer patients find questions about cancer fatalismacceptable? A preliminary report. J Cancer Educ 2011;26:3-4
29. Sheppard VB, Davis K, Boisvert M, Jennings Y, Montalvo B. Do recently diagnosed black breast cancer patients find questions about cancer fatalism acceptable? A preliminary report. J Cancer Educ 2011;26:5-10.
30. NHS England. Knowing the signs of cancer could save your life. Be clear on cancer. http://www.nhs.uk/be-clear-on-cancer/.
31. American Cancer Society. Signs and symptoms of cancer. http://www. cancer.org/cancer/cancerbasics/signs-and-symptoms-of-cancer.